...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!

 "I could be dreaming but the potentional in a few years is there"

no arguement here or on anything else you pointed out.

I'd just like to ride that wave on the Naz + look at the price were doing PP's for now compared to your valuations, its brutal.

With the right people leading the way to a Naz listing this thing would soar + make the next 2-3 years a bit more enjoyable/interesting IMO.

Share
New Message
Please login to post a reply